Nobel Biocare launching two new implant systems
Nobel Biocare launching two new implant systems Nobel Biocare's target is to introduce at least two major products every year within business area Dental Implants. Now, two innovative product systems are being launched within the brands Brånemark System® and Steri-Oss®. The new implant Brånemark System Mk III is a universal fixture which considerably simplifies treatment as a result of its innovative design. The Steri-Oss Replace Select is a comprehensive and flexible system that makes one-stage implant treatment possible, thereby helping to shorten treatment times for dentists and patients alike. "These new products have been given an excellent reception in the USA and Sweden and initial sales have surpassed our forecasts. In recent years, Nobel Biocare has effectively streamlined the development of new products and realized its target of ensuring that 30% of sales are generated by products launched during the past three years. Product development focuses on simplifying and shortening treatment for dentists and bringing about a long- term reduction in the cost to the patient in order to increase the use of dental implants," says Jack Forsgren, president of Nobel Biocare AB. Fixture sales account for a large part of Nobel Biocare's total sales. Nobel Biocare has a 40% share of the world market, following the successful acquisition of the leading US implant company Steri-Oss. The total market value of dental implants is around SEK 4 billion and the market is expected to grow by some 10% this year. Göteborg, October 11, 1999 NOBEL BIOCARE AB For more information please contact: Jack Forsgren, President and CEO or Carsten Browall, Executive Vice President, Nobel Biocare AB, telephone +41 31-81 88 00. Nobel Biocare is an innovative, medical devices company, whose core business comprises dental implants and dental prosthetics. The company's product systems for dental implants, Brånemark System® and Steri-Oss®, are world leaders and have a global market share of around 40%. The company's other product line, Procera®, is a unique, patented CAD/CAM- based process for the industrial production of dental prosthetics. The system has been launched very successfully in North America and Europe. Nobel Biocare has around 1,000 employees and, in 1998, turnover totalled SEK 1,310 million. The company's headquarters are located in Gothenburg, Sweden, while production takes place in Sweden and the USA. Nobel Biocare has its own sales companies in some 20 countries. Nobel Biocare is listed on the Swedish Stock Exchange. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/10/11/19991011BIT00350/bit0001.doc http://www.bit.se/bitonline/1999/10/11/19991011BIT00350/bit0002.pdf